From: FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
Training cohort (n = 36) | Validation cohort (n = 36) | |
---|---|---|
Age (range) | 64 (40–67) | 66 (49–76) |
Gender (%) - Male - Female | 34 (94) 2 (6) | 30 (83) 6 (17) |
Histology (%) - Epithelioid - Biphasic - Sarcomatoid | 31 (86) 4 (11) 1 (3) | 30 (83) 5 (14) 1 (3) |
Surgery (%) - P/D - EPP | 23 (64) 13 (36) | 30 (83) 6 (17) |
Induction chemotherapy (%) | 25 (69) | 35 (97) |